Expertise in
3
conditions

Gaetano Facchini

Naples, IT 
Expertise in
3
conditions
Naples, IT 

Overview

Gaetano Facchini practices practicing medicine in Naples, Italy.

Mr. Facchini is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Penile Cancer, Nephrectomy, and Prostatectomy.

He is actively involved in clinical research, co-authoring 188 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Naples, Italy
Other Locations
Pozzuoli, 80078, Italy
Bologna, Italy
Asl, 80078, Italy
Catania, Italy
Cura, Italy
Aviano, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomized, Multicentre Phase II Trial of the Sequencing of Radium-223 and Docetaxel Plus Prednisone in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cancer (mCRPC)
Randomized, Multicentre Phase II Trial of the Sequencing of Radium-223 and Docetaxel Plus Prednisone in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment Status: Active_not_recruiting
Publish Date: September 27, 2024
Intervention Type: Drug
Study Drugs: Radium-223, Docetaxel
Study Phase: Phase 2
ODM-201 Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) Previously Treated With Novel Hormonal Agents and Non-progressive Disease After Subsequent Treatment With a Taxane: A Multicenter Randomized Double-blind Placebo-controlled Phase II Trial.
ODM-201 Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) Previously Treated With Novel Hormonal Agents and Non-progressive Disease After Subsequent Treatment With a Taxane: A Multicenter Randomized Double-blind Placebo-controlled Phase II Trial.
Enrollment Status: Terminated
Publish Date: March 13, 2024
Intervention Type: Other, Drug
Study Drug: ODM-201
Study Phase: Phase 2
View 1 Less Clinical Trial

188 Total Publications

Darolutamide versus abiraterone acetate-based triplets in patients with hormone-sensitive prostate cancer: real-world, head-to-head comparison from the ARON-3 study.
Darolutamide versus abiraterone acetate-based triplets in patients with hormone-sensitive prostate cancer: real-world, head-to-head comparison from the ARON-3 study.
Journal: Minerva urology and nephrology
Published: June 23, 2026

Frequently Asked Questions about Gaetano Facchini

Is Gaetano Facchini a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Gaetano Facchini is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gaetano Facchini participate in research or clinical trials?

Yes. Gaetano Facchini has published 188 articles and abstracts on conditions like Prostate Cancer. You can view a list of Gaetano Facchini's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Facchini's expertise for a condition
ConditionClose
    View All 35 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile